文献速递复苏、休克与脓毒症心脑血管急症

成人心脏骤停中骨髓腔内与静脉血管通路:系统评价与Meta分析

Intraosseous and intravenous vascular access during adult cardiac arrest: a systematic review and meta-analysis.
PubMed 文献 · Resuscitation · 2026-02-26
一句话结论成人院外心脏骤停初始尝试骨髓腔内通路与静脉通路相比未改善30天生存,且可能降低持续自主循环恢复的几率。

该系统评价与Meta分析检索MEDLINE、Embase、Cochrane图书馆及国际临床试验注册平台至2024年9月4日,纳入比较成人心脏骤停中骨髓腔内与静脉通路的随机临床试验。最初纳入3项试验,其中1项随后被撤稿,最终纳入2项试验共7561例院外心脏骤停参与者。初始尝试骨髓腔内通路相比静脉通路未增加30天生存的几率(OR 0.97,95%CI 0.80-1.18;7540例;2项试验;中等确定性证据),也未增加30天/出院时良好神经功能结局的几率(OR 1.03,95%CI 0.81-1.31;7454例;2项试验;低确定性证据);骨髓腔内组达到持续自主循环恢复的几率更低(OR 0.89,95%CI 0.80-0.99;7518例;2项试验;中等确定性证据)。

要点

  • 成人院外心脏骤停初始尝试骨髓腔内通路与静脉通路相比,30天生存无显著差异(OR 0.97,95%CI 0.80-1.18;7540例;中等确定性证据)。
  • 骨髓腔内组达到持续自主循环恢复的几率低于静脉组(OR 0.89,95%CI 0.80-0.99;7518例;中等确定性证据)。
  • 30天/出院时良好神经功能结局在两组间无显著差异(OR 1.03,95%CI 0.81-1.31;7454例;低确定性证据)。
  • 该系统评价最初纳入3项随机临床试验,其中1项随后被撤稿,最终仅2项试验纳入分析。

适用人群与场景

  • 成人院外心脏骤停患者,来自2项随机临床试验共7561例参与者。

研究设计与关键结果

  • 研究类型:系统评价与Meta分析,纳入2项随机临床试验(最初纳入3项,其中1项随后被撤稿),共7561例成人院外心脏骤停参与者。
  • 主要终点:初始尝试骨髓腔内通路与静脉通路相比,30天生存的OR为0.97(95%CI 0.80-1.18;7540例;2项试验;中等确定性证据),无显著差异。
  • 关键次要终点:30天/出院时良好神经功能结局OR为1.03(95%CI 0.81-1.31;7454例;2项试验;低确定性证据),无显著差异。
  • 关键次要终点:持续自主循环恢复的OR为0.89(95%CI 0.80-0.99;7518例;2项试验;中等确定性证据),骨髓腔内组几率更低。
  • Meta分析采用固定效应模型;偏倚风险使用Cochrane Risk of Bias-2工具评估;证据确定性使用GRADE方法评估。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入随机临床试验;证据确定性采用GRADE分级:30天生存为中等确定性,良好神经功能结局为低确定性,持续自主循环恢复为中等确定性。
  • 局限:最初纳入的3项随机临床试验中1项随后被撤稿,最终仅2项试验纳入分析。

对床旁实践的改变

  • 作者结论:成人心脏骤停中初始尝试骨髓腔内通路与静脉通路相比未改善30天生存,且可能降低持续自主循环恢复的几率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To summarise evidence on the clinical effectiveness of initial vascular attempts via the intraosseous route compared to the intravenous route in adult cardiac arrest.

METHODS: We searched MEDLINE and Embase (OVID platform), the Cochrane library, and the International Clinical Trials Registry Platform from inception to September 4th 2024 for randomised clinical trials comparing the intraosseous route with the intravenous route in adult cardiac arrest. Our primary outcome was 30-day survival. Secondary outcomes included favourable neurological outcome at 30-days/hospital discharge and return of spontaneous circulation (both any ROSC and sustained ROSC). We performed meta-analyses using a fixed-effect model. We assessed risk of bias using the Cochrane Risk of Bias-2 tool and evidence certainty using the GRADE approach.

RESULTS: We originally included three randomised clinical trials, but one trial was subsequently retracted. As such, two trials were included encompassing 7561 participants with out-of-hospital cardiac arrest. Initial attempts via the intraosseous, compared with intravenous, route did not increase the odds of 30-day survival (odds ratio 0.97, 95% confidence interval 0.80-1.18; 7540 participants; two trials; moderate-certainty evidence) or favourable neurological outcome at 30-days/hospital discharge (odds ratio 1.03, 95% confidence interval 0.81-1.31; 7454 participants; two trials; low-certainty evidence). The odds of achieving sustained return of spontaneous circulation were lower in the intraosseous group (odds ratio 0.89, 95% confidence interval 0.80-0.99; 7518 participants; two trials; moderate-certainty evidence).

CONCLUSION: Initial vascular access attempts via the intraosseous, compared with intravenous, route in adult cardiac arrest did not improve 30-day survival and may reduce the odds of a sustained return of spontaneous circulation.

REGISTRATION: PROSPERO CRD42024577647.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Couper K, Andersen LW, Drennan IR, et al. Intraosseous and intravenous vascular access during adult cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2026. PMID: 41760477. doi:10.1016/j.resuscitation.2026.111015

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。